Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sensors (Basel) ; 23(19)2023 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-37837057

RESUMO

Everyday tasks use sensors to monitor and provide information about processes in different scenarios, such as monitoring devices in manufacturing or homes. Sensors need to communicate, with or without wires, while providing secure information. Power can be derived from various energy sources, such as batteries, electrical power grids, and energy harvesting. Energy harvesting is a promising way to provide a sustainable and renewable source to power sensors by scavenging and converting energy from ambient energy sources. However, low energy is harvested through these methods. Therefore, it is becoming a challenge to design and deploy wireless sensor networks while ensuring the sensors have enough power to perform their tasks and communicate with each other through careful management and optimization, matching energy supply with demand. For this reason, data cryptography and authentication are needed to protect sensor communication. This paper studies how energy harvested with microbial fuel cells can be employed in algorithms used in data protection during sensor communication.


Assuntos
Fontes de Energia Bioelétrica , Eletricidade , Fontes Geradoras de Energia , Redes de Comunicação de Computadores , Algoritmos
2.
Plants (Basel) ; 11(8)2022 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-35448748

RESUMO

Durum wheat is one of the largest cultivated crops across Mediterranean areas. The high demand for sustainable crop productions, especially concerning weed management, is driving the return to local landraces. In the present work, the in vitro allelopathic effects of the extracts of three durum wheat landraces ('Timilia', 'Russello' and 'Perciasacchi') and a modern variety ('Mongibello'), obtained from three different plant parts (ears, stems and roots), were tested on seed germination (G) and mean germination time (MGT) of Portulaca oleracea L. and Stellaria. media (L.) Vill., two weeds commonly infesting wheat fields. In addition, the total polyphenol (TPC) and total flavonoid (TFC) content of extracts was determined. All extracts reduced G and increased MGT in both weeds compared to the control. The magnitude of phytotoxicity was strongly affected by the influence of genotype, plant part and extract dilution. Overall, the landraces 'Timilia' and 'Russello' showed the highest allelopathic effects, ear extracts were the most active, and the maximum extract dilution induced higher phytotoxicity. Extracts' TPC and TFC corroborated these results. The findings obtained here encourage the use of local landraces as a source of allelochemicals and suggest that they could be left on soil surface or soil-incorporated after harvest for a possible weed control.

4.
Dermatol Ther ; 32(5): e13021, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31306540

RESUMO

Psoriasis impacts the quality of life (QoL) by disrupting overall health and social life. Thus, the use of a QoL evaluation item is crucial in assessing a therapeutic regimen. Also, faster improvements in QoL lead to better patient compliance, but very few studies compare psoriasis traditional and biologic therapies timing. To evaluate how much different systemic therapies improve disease severity and QoL, a retrospective analysis was performed on 56 patients. Subjects were administered different drugs and their vital statistics, psoriasis area severity index (PASI) and PSOdisk were collected at baseline and after 30 days. We found a moderate correlation between PASI and PSOdisk score with (r): .62. In terms of clinical scores improvement after 30 days, Ustekinumab turned out to be the fastest therapy available, while cyclosporine, among the systemic therapies available, appeared as highly competitive if not better than other biologic therapies.


Assuntos
Adalimumab/uso terapêutico , Terapia Biológica/métodos , Ciclosporina/uso terapêutico , Psoríase/terapia , Qualidade de Vida , Ustekinumab/uso terapêutico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anti-Inflamatórios/uso terapêutico , Fármacos Dermatológicos/uso terapêutico , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Psoríase/diagnóstico , Psoríase/psicologia , Estudos Retrospectivos , Índice de Gravidade de Doença , Pele/patologia , Inquéritos e Questionários , Fatores de Tempo , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...